With Double Digit Growth Rates and Strong Product Pipeline, the Emerging Cardiac Devices Market will Witness a Transformation in the Next 5 Years
The biggest challenge for emerging cardiac procedures is adoption barrier and reimbursement. The long-term clinical evidence gathered through clinical studies and the technological improvement in the product pipeline has addressed the adoption barrier and reimbursement coverage based on morbidity of the patients is the first step towards increased adoption. The market trends, revenue forecasts, and competitive trends for each of the four segments are discussed in detail.
The research contains data about four of the emerging cardiac devices/procedures market. Cardiac Procedures developed conventionally was to address the cardiac condition. Today, most procedures and products developed are to address the ailment of the patients that cannot be supported with conventional procedures and devices. The market dynamics of these emerging procedures and devices are greatly determined the upcoming product launches and product pipeline.
The report encompasses an overview of emerging cardiac therapies with key findings. The emerging trends and technologies in the interventional cardiac sector and its potential market dynamics are also discussed. The analysis provides a roadmap for companies in cardiac sector to understand the emerging cardiac technologies and help them to prepare and stay competitive for the changing landscape of cardiac surgeries. Regions include United States and Western Europe (Germany, France, Spain, Italy, and the United Kingdom).
This report provides revenue forecasts, reimbursement trends, and top company profiles of key segments such as Transcatheter Aortic Valve Implantation (TAVI), Transcatheter Mitral Valve Repair (TMVR), Endovascular Aortic Repair (EVAR), and Left Ventricular Assisted device (LVAD).
Key Questions this Study will Answer
- What are the technological evolutions in the cardiac procedures and how will they impact the overall cardiac sector?
- Which are the most promising technologies in the emerging cardiac therapies?
- How will the cardiac companies continue to exist through product innovations or inorganic growth?
- What are the regulatory challenges faced by the device manufacturers?
- Are the cardiac products offered today meeting customer needs or is additional development needed?
Table of Contents
1. EXECUTIVE SUMMARY
- 1. Key Findings
- 2. Emerging Interventional Cardiac Procedures
- 3. Scope and Segmentation
- 4. Key Questions this Study will Answer
- 5. Measurements-Transcatheter Aortic Valve Implantation Market
- 6. Measurements-Transcatheter Mitral Valve Repair Market
- 7. Measurements-Left Ventricular Assisted Device Market
- 8. Measurements-Endovascular Aortic Repair (EVAR) Market
- 9. CEO's Perspective
2. INTRODUCTION TO EMERGING CARDIAC THERAPIES
- 1. Cardiovascular Care Continuum and Scope of the Study
3. TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)
- 1. Facts on Aortic Stenosis
- 2. Measurements
- 3. TAVI Market Analysis
4. INFRASTRUCTURE AND RESOURCE TRENDS
- 1. TAVI Infrastructure and Resource Trends
5. REIMBURSEMENT TRENDS
- 1. Reimbursement for TAVI
- 2. Reimbursement for TAVI (continued)
6. PRODUCT PIPELINE
- 1. Evolution
- 2. Technologically Driven Market
- 3. TAVI Pipeline Products-2015-2020
- 4. TAVI Pipeline Products-2015-2020 (continued)
- 5. TAVI Pipeline Products-2015-2020 (continued)
7. COMPETITIVE PLAYBOOK
- 1. Edwards Lifesciences
- 2. Edwards Lifesciences (continued)
- 3. Medtronic
- 4. Medtronic (continued)
- 5. Boston Scientific
- 6. Boston Scientific (continued)
- 7. Dashboard Summary of TAVI Market
8. MARKET SUMMARY
9. TRANSCATHETER MITRAL VALVE REPAIR (TMVR)
- 1. Facts on Mitral Regurgitation
- 2. Measurements
- 3. TMVR Market Analysis
10. INFRASTRUCTURE AND RESOURCE TRENDS
- 1. TMVR Infrastructure and Resource Trends
11. REIMBURSEMENT TRENDS
- 1. Reimbursement for TMVR
- 2. Reimbursement for TMVR (continued)
- 3. Reimbursement for TMVR (continued)
- 4. Reimbursement for TMVR (continued)
12. PRODUCT PIPELINE
- 1. Evolution
- 2. Product Portfolio for TMVR
- 3. Companies to Grab TMVR Market Share through M&As
- 4. TMVR Pipeline Products-2015-2020
- 5. TMVR Pipeline Products-2015-2020 (continued)
- 6. TMVR Pipeline Products-2015-2020 (continued)
- 7. TMVR Clinical Trials-2015-2020
13. COMPETITIVE PLAYBOOK
- 1. Abbott Vascular
- 2. Abbott Vascular (continued)
- 3. Dashboard Summary of TMVR Market
14. MARKET SUMMARY
15. LEFT VENTRICULAR ASSISTED DEVICES (LVAD)
- 1. Facts on Heart Failure
- 2. Measurements
- 3. Types of LVAD Therapies
- 4. LVAD Market Analysis
16. INFRASTRUCTURE AND RESOURCE TRENDS
- 1. LVAD Infrastructure and Resource Trends
- 2. Evolution of LVAD
- 3. Evolution of LVAD by Technology
17. REIMBURSEMENT TRENDS
- 1. Reimbursement for LVAD
- 2. Reimbursement for LVAD (continued)
- 3. Reimbursement for LVAD (continued)
18. COMPETITIVE PLAYBOOK
- 1. Intense Competition Bolsters-M&As in LVAD Industry
- 2. St. Jude-An Abbott Company
- 3. St. Jude-An Abbott Company (continued)
- 4. St. Jude-An Abbott Company (continued)
- 5. HeartWare
- 6. HeartWare (continued)
- 7. Thoratec (a St. Jude Company)
- 8. Competitive Product Profiling
- 9. Product Portfolio for LVAD
- 10. Dashboard Summary of LVAD Market
19. MARKET SUMMARY
20. ENDOVASCULAR AORTIC REPAIR (EVAR)
- 1. Facts on Heart Failure
- 2. Measurements
- 3. EVAR Market Analysis
- 4. EVAR Market Opportunity Analysis
21. REIMBURSEMENT TRENDS
- 1. Reimbursement for EVAR
- 2. Reimbursement for EVAR (continued)
- 3. Reimbursement for EVAR (continued)
- 4. Reimbursement for EVAR (continued)
- 5. Evolution of EVAR
- 6. Evolution of EVAR by Technology
- 7. Companies to Grab EVAR Market Share Through M&As
22. COMPETITIVE PLAYBOOK
- 1. Medtronic
- 2. Medtronic (continued)
- 3. Cook Medical
- 4. Cook Medical (continued)
- 5. WL Gore
- 6. WL Gore (continued)
- 7. Endologix
- 8. Endologix (continued)
- 9. Dashboard Summary of EVAR Market
23. MARKET SUMMARY
24. FUTURE PERSPECTIVES
- 1. Future Perspectives-3 Big Predictions
- 2. Legal Disclaimer
25. APPENDIX
